Piceatannol
|
WikiDoc Resources for Piceatannol |
|
Articles |
|---|
|
Most recent articles on Piceatannol Most cited articles on Piceatannol |
|
Media |
|
Powerpoint slides on Piceatannol |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Piceatannol at Clinical Trials.gov Clinical Trials on Piceatannol at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Piceatannol
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Piceatannol Discussion groups on Piceatannol Patient Handouts on Piceatannol Directions to Hospitals Treating Piceatannol Risk calculators and risk factors for Piceatannol
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Piceatannol |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Piceatannol (3,4,3',5'-tetrahydroxy-trans-stilbene) is a phenolic. It is a metabolite of resveratrol, so its not surpising that it is found in red wine. LMP2A, a viral protein tyrosine kinase implicated in leukemia, Non-Hodgkin's lymphoma, and other diseases associated with Epstein-Barr Virus, were found to be blocked by picetannol in vitro, and a target for therapeutic anti-cancer and anti-EBV drugs.[1]